FDA Heeds Our Concerns and Bans DMAA Products Consumer News FDA Heeds Our Concerns and Bans DMAA Products Agency prohibits products with DMAA from entering market.
Jack3d Marketed as Safe Despite Reports of Deaths Consumer News Jack3d Marketed as Safe Despite Reports of Deaths DOJ files an indictment against USPlabs and top execs.
GNC: No Stranger To Regulatory Enforcement Consumer News GNC: No Stranger To Regulatory Enforcement False advertising and wrongful death are among a plethora of allegations filed against the supplement retailer.
Study Calls on FDA to Act on Stimulant Found in Weight-Loss Products Consumer News Study Calls on FDA to Act on Stimulant Found in Weight-Loss Products Amphetamine-like ingredient found in Acacia rigidula dietary supplements could trigger harmful reactions.
Purus Labs, Inc Ad Alert Purus Labs, Inc The FDA sent a warning letter to Formulife, Inc./Purus Labs, Inc., after the dietary supplement maker was found to be selling products containing DMAA, which has been banned by the…
What You Should Know about Plexus Consumer News What You Should Know about Plexus TINA.org investigation of the pink drink company finds inappropriate health and income claims.
BPI Sports Ad Alert BPI Sports BPI Sports, a supplement company, discontinued some of its advertising claims after the claims were challenged by the Council for Responsible Nutrition. The National Advertising Division (NAD) is the advertising…
FDA Warns Companies about Dangers of Stimulants in Supplements Consumer News FDA Warns Companies about Dangers of Stimulants in Supplements Eight products found to have BMPEA and 17 products contain DMBA, both amphetamine-like stimulants.
Weekly Legal Roundup Blog Weekly Legal Roundup Diamonds, energy supplements and cholesterol reducing drugs made legal headlines in the I-think-you’re-lying-to-me category during the week of February 11, 2013. Two new false advertising actions were filed: It’s a…
FDA & Dietary Supplements: By the Numbers Consumer News FDA & Dietary Supplements: By the Numbers Is the FDA doing enough to monitor the supplement industry?